Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Absence of NR2E1 mutations in patients with aniridia.
[aniridia]
Nuclear
receptor
2
E
1
(
NR
2
E
1
)
is
a
transcription
factor
with
many
roles
during
eye
development
and
thus
may
be
responsible
for
the
occurrence
of
certain
congenital
eye
disorders
in
humans
.
To
test
this
hypothesis
,
we
screened
NR
2
E
1
for
candidate
mutations
in
patients
with
aniridia
and
other
congenital
ocular
malformations
(
anterior
segment
dysgenesis
,
congenital
optic
nerve
malformation
,
and
microphthalmia
)
.
The
NR
2
E
1
coding
region
,
5
'
and
3
'
untranslated
regions
(
UTRs
)
,
exon
flanking
regions
including
consensus
splice
sites
,
and
six
evolutionarily
conserved
non-coding
candidate
regulatory
regions
were
analyzed
by
sequencing
58
probands
with
aniridia
of
whom
42
were
negative
for
PAX
6
mutations
.
Nineteen
probands
with
anterior
segment
dysgenesis
,
one
proband
with
optic
nerve
malformation
,
and
two
probands
with
microphthalmia
were
also
sequenced
.
The
control
population
comprised
376
healthy
individuals
.
All
sequences
were
analyzed
against
the
GenBank
sequence
AL
078596
.
8
for
NR
2
E
1
.
In
addition
,
the
coding
region
and
flanking
intronic
sequences
of
FOXE
3
,
FOXC
1
,
PITX
2
,
CYP
1
B
1
,
PAX
6
,
and
B
3
GALTL
were
sequenced
in
one
patient
and
his
relatives
.
Sequencing
analysis
showed
17
NR
2
E
1
variants
including
two
novel
rare
non-coding
variants
(
g
.
-
1507
G
>
A
,
g
.
14258
C
>
T
)
,
and
one
novel
rare
coding
variant
(
p
.
Arg
274
Gly
)
.
The
latter
was
present
in
a
male
diagnosed
with
Peters
'
anomaly
who
subsequently
was
found
to
have
a
known
causative
mutation
for
Peters
'
plus
syndrome
in
B
3
GALTL
(
c
.
660
+
1
G
>
A
)
.
In
addition
,
the
NR
2
E
1
novel
rare
variant
Arg
274
G
ly
was
present
in
the
unaffected
mother
of
the
patient
but
absent
in
746
control
chromosomes
.
We
eliminated
a
major
role
for
NR
2
E
1
regulatory
and
coding
mutations
in
aniridia
and
found
a
novel
rare
coding
variant
in
NR
2
E
1
.
In
addition
,
we
found
no
coding
region
variation
in
the
control
population
for
NR
2
E
1
,
which
further
supports
its
previously
reported
high
level
of
conservation
and
low
genetic
diversity
.
Future
NR
2
E
1
studies
in
ocular
disease
groups
such
as
those
involving
retinal
and
optic
nerve
abnormalities
should
be
undertaken
to
determine
whether
NR
2
E
1
plays
a
role
in
these
conditions
.
Diseases
Validation
Diseases presenting
"thus may be responsible for the occurrence of certain congenital eye disorders in humans"
symptom
aniridia
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom